Browse > Article
http://dx.doi.org/10.14456/apjcp.2016.228/APJCP.2016.17.8.4143

Accuracy of FDG-PET/CT for Detection of Incidental Pre-Malignant and Malignant Colonic Lesions - Correlation with Colonoscopic and Histopathologic Findings  

Kunawudhi, Anchisa (Division of Precision Medicine, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School)
Wong, Alexandra K (Division of Precision Medicine, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School)
Alkasab, Tarik K (Department of Radiology, Massachusetts General Hospital, Harvard Medical School)
Mahmood, Umar (Division of Precision Medicine, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.17, no.8, 2016 , pp. 4143-4147 More about this Journal
Abstract
Purpose: We evaluated all PET/CTs acquired for patients without a primary diagnosis of colorectal cancer, and compared results for those who had subsequent colonoscopy within 6 months, to assess the accuracy of FDG PET/CT for detection of incidental pre-malignant polyps and malignant colon cancers. Materials and Methods: Medical records of 9,545 patients who underwent F-18 FDG PET/CT studies over 3.5 years were retrospectively reviewed. Due to pre-existing diagnosis of colorectal cancer, 818 patients were excluded. Of the remainder, 157 patients had colonoscopy within 6 months (79 males; mean age 61). We divided the colon into 4 regions and compared PET/CT results for each region with colonoscopy and histopathologic findings. True positive lesions included colorectal cancer, villous adenoma, tubulovillous adenoma, tubular adenoma and serrated hyperplastic polyp/hyperplastic polyposis. Results: Of 157 patients, 44 had incidental colonic uptake on PET/CT (28%). Of those, 25 had true positive (TP) uptake, yielding a 48% positive predictive value (PPV); 9% (4/44) were adenocarcinoma. There were 23 false positive (FP) lesions of which 4 were hyperplastic polyp, one was juvenile polyp and 7 were explained by diverticulitis. Fifty eight patients had false negative PET scans but colonoscopy revealed true pre-malignant and malignant pathology, yielding 23% sensitivity. The specificity, negiative predictive value (NPV) and accuracy were 96%, 90% and 87%, respectively. The average SUVmax values of TP, FP and FN lesions were 7.25, 6.11 and 2.76, respectively. There were no significant difference between SUVmax of TP lesions and FP lesions (p>0.95) but significantly higher than in FN lesions (p<0.001). The average size (by histopathology and colonoscopy) of TP lesions was 18.1 mm, statistically different from that of FN lesions which was 5.9 mm (p<0.001). Fifty-one percent of FN lesions were smaller than 5 mm (29/57) and 88% smaller than 10 mm (50/57). Conclusions: The high positive predictive value of incidental focal colonic FDG uptake of 48% for colonic neoplasia suggests that colonoscopy follow-up is warranted with this finding. We observed a low sensitivity of standardly acquired FDG-PET/CT for detecting small polyps, especially those less than 5 mm. Clinician and radiologists should be aware of the high PPV of focal colonic uptake reflecting pre-malignant and malignant lesions, and the need for appropriate follow up.
Keywords
PET/CT; screening; colon cancer; pre-malignant; incidental findings;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Weston BR, Iyer RB, Qiao W, et al (2010). Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer, 116, 1454-61.   DOI
2 Friedland S, Soetikno R, Carlisle M, et al (2005). 18-Fluorodeoxyglucose positron emission tomography has limited sensitivity for colonic adenoma and early stage colon cancer. Gastrointest Endosc, 61, 395-400.   DOI
3 Fuertes J, Montagut C, Bullich S, et al (2015). Incidental focal uptake in colorectal location on oncologic (1)(8)FDG PET and PET/CT studies: histopathological findings and clinical significances. Rev Esp Med Nucl Imagen Mol, 34, 95-101.
4 Gutman F, Alberini JL, Wartski M, et al (2005). Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol, 185, 495-500.   DOI
5 Nakajo M, Jinnouchi S, Tashiro Y, et al (2009). Effect of clinicopathologic factors on visibility of colorectal polyps with FDG PET. AJR Am J Roentgenol, 192, 754-60.   DOI
6 Keyzer C, Dhaene B, Blocklet D, et al (2015). Colonoscopic Findings in Patients With Incidental Colonic Focal FDG Uptake. AJR Am J Roentgenol, 204, 586-91.   DOI
7 Lee JC, Hartnett GF, Hughes BG, et al (2009). The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PETCT. Nucl Med Commun, 30, 333-7.   DOI
8 Na SY, Kim KJ, Han S, et al (2015). Who should undergo a colonoscopy among patients with incidental colon uptake on PET-CT? Scand J Gastroenterol, 50, 1045-53.   DOI
9 Peng J, He Y, Xu J, et al (2011). Detection of incidental colorectal tumours with 18F-labelled 2- fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Colorectal Dis, 13, 374-8.   DOI
10 Prabhakar HB, Sahani DV, Fischman AJ, et al (2007). Bowel hot spots at PET-CT. Radiographics, 27, 145-59.   DOI
11 Purandare NC, Gawade SK, Puranik AD, et al (2012). Etiology and significance of incidentally detected focal colonic uptake on FDG PET/CT. Indian J Radiol Imaging, 22, 260-6.   DOI
12 Rainis T, Kaidar-Person O, Keren D, et al (2014). Correlation between incidental FDG PET/CT colorectal observations and endoscopic and histopathological results. Oncol Lett, 7, 479-82.   DOI
13 Sone Y, Sobajima A, Kawachi T, et al (2014). Ability of 18-fludeoxyglucose positron emission tomography/CT to detect incidental cancer. Br J Radiol, 87, 20140030.   DOI
14 Salazar Andia G, Prieto Soriano A, Ortega Candil A, et al (2011). Clinical relevance of incidental finding of focal uptakes in the colon during (18)F-FDG PET/CT studies in oncology patients without known colorectal carcinoma and evaluation of the impact on management. Rev Esp Med Nucl. 31, 15-21.
15 Seivert M, Plomteux O, Colard A, et al (2014). Endoscopic findings in case of incidental colonic uptake in PET-CT how to improve PET-CT specificity? Acta Gastroenterol Belg, 77, 413-7.
16 Simsek FS, Ispiroglu M, Tasdemir B, et al (2015). What approach should we take for the incidental finding of increased 18F-FDG uptake foci in the colon on PET/CT? Nucl Med Commun, 36, 1195-201.   DOI
17 Stewart BW, Wild CP (2014). World cancer report 2014, Lyon, IARC Press.
18 Tatlidil R, Jadvar H, Bading JR, et al (2002). Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiol, 224, 783-7.   DOI
19 van Hoeij FB, Keijsers RG, Loffeld BC, et al (2015). Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy? Eur J Nucl Med Mol Imaging, 42, 66-71.   DOI
20 van Kouwen MC, Nagengast FM, Jansen JB, et al (2005). 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol, 23, 3713-7.   DOI
21 Rosenbaum SJ, Lind T, Antoch G, et al (2006). False-positive FDG PET uptake-the role of PET/CT. Eur Radiol, 16, 1054-65.   DOI